Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
Lancelotta, R. L., & Davis, A. K. | Journal of Psychoactive Drugs | 09 Mar 2020
Psilocybin Therapeutic Research: The Present and Future Paradigm
Kargbo, R. B. | ACS Medicinal Chemistry Letters | 2 March 2020
Subacute Effects of the Psychedelic Ayahuasca on the Salience and Default Mode Networks
Pasquini, L., Palhano-Fontes, F., & de Araujo, D. B. | medRxiv | 21 February 2020
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. | Journal of Psychopharmacology | 16 January 2020
Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity
Preller, K. H., Duerler, P., Burt, J. B., Ji, J. L., Adkinson, B., Stämpfli, P., Anticevic, A. | Biological Psychiatry | 13 January 2020
Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
Basso, L., Bönke, L., Aust, S., Gärtner, M., Heuser-Collier, I., Otte, C., ... & Grimm, S. | Journal of Psychiatric Research | 13 January 2020